How femtech companies are tackling gender health gaps while empowering women. From left to right: Rachel Bartholomew, CEO and Founder of Hyivy Health, Nadia Ladak, CEO and Co-founder of Marlow, Dallas Barnes, CEO and founder of Reya Health
0 comments / 0 votes

Growing a femtech company brings more challenges than successes, but these founders are focused on closing the women’s healthcare gap.

0 comments / 0 votes
0 comments / 0 votes

McMaster and University of Ottawa recieved funding from CBRF to expand Canada’s biomanufacturing industry for development of technology and theraputics.

0 comments / 0 votes
Success stories inspire the next generation of unicorn founders. Background image shows a diverse group of entrepreneurs celebrating business success in a bright office environment.
0 comments / 0 votes

Blockbuster AstraZeneca-Fusion Pharmaceuticals announcement shows Hamilton’s life science innovation ecosystem is thriving.

0 comments / 0 votes
In the news: Fusion Pharmaceuticals. The background image is a woman researcher working in a lab while wearing personal protective equipment (PPE).
0 comments / 0 votes

Hamilton-based Fusion Pharmaceuticals Inc. has entered into a definitive agreement to be acquired by AstraZeneca.

0 comments / 0 votes
PreOperative Performance is a SOPHIE company partnering with The Research Institute of St. Joes Hamilton to to help neuroradiologists to assess the quality and consistency of MRI diffusion imaging protocols.
0 comments / 0 votes

Through the SOPHIE program, PreOperative Performance will enter a 12-month co-development partnership with The Research Institute of St. Joe’s Hamilton (RSJH) to evaluate technology that aims to help radiology groups make better quality measurements of MRI machines. This press release was originally shared by PreOperative Performance through Newswire on June 14, 2023. Read the original […]

0 comments / 0 votes
0 comments / 0 votes

This press release was originally published by Fusion Pharmaceuticals on April 12, 2023. Read the original post here. FPI-2068 is a Bispecific Targeted Alpha Therapy (TAT) designed to Precisely Deliver Radiation to Tumor Cells HAMILTON, ON and BOSTON, April 12, 2023 /– Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision […]

0 comments / 0 votes
0 comments / 0 votes

Making a smart site selection could drive the commercialization of your intellectual property. Here are three examples that are helping to make Hamilton, Ontario, the next leader in life sciences research and commercialization.

0 comments / 0 votes

Archives

> <
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec